Long non-coding RNA/epithelial-mesenchymal transition axis in human cancers: Tumorigenesis, chemoresistance, and radioresistance

Hashemi M., Hajimazdarany S., Mohan C. D., Mohammadi M., Rezaei S., Olyaee Y., ...Daha Fazla

Pharmacological Research, cilt.186, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 186
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1016/j.phrs.2022.106535
  • Dergi Adı: Pharmacological Research
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, Aquatic Science & Fisheries Abstracts (ASFA), BIOSIS, Biotechnology Research Abstracts, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
  • Anahtar Kelimeler: Exosomes, Metastasis, Non-coding RNA, Brain tumors, Gastrointestinal tumors, Gynecological and urological tumors, CELL LUNG-CANCER, SUPEROXIDE-DISMUTASE EXPRESSION, HEPATOCELLULAR-CARCINOMA CELLS, TRANSCRIPTION FACTOR SNAIL, EPITHELIAL OVARIAN-CANCER, EXOSOME-MEDIATED TRANSFER, PROMOTES EMT PROCESS, GASTRIC-CANCER, CISPLATIN-RESISTANCE, BLADDER-CANCER
  • Kayseri Üniversitesi Adresli: Hayır

Özet

© 2022 Elsevier LtdEpithelial-to-mesenchymal transition (EMT) is a process that involves the transformation of polarized epithelial cells to attain a mesenchymal phenotype that presents an elevated migratory potential, invasiveness, and antiapoptotic properties. Many studies have demonstrated that EMT is a prominent event that is associated with embryogenesis, tumor progression, metastasis, and therapeutic resistance. The EMT process is driven by key transcription factors (such as Snail, Twist, ZEB, and TGF-β) and several long non-coding RNAs (lncRNAs) in many non-pathological as well as pathological conditions. In the present report, we have comprehensively discussed the oncogenic and tumor suppressor role of lncRNAs and their mechanism of action in the regulation of the EMT process in various cancers such as brain tumors, gastrointestinal tumors, and gynecological and urological tumors. We have also elaborated on the role of lncRNAs in the regulation of EMT-related transcription factors (such as Snail, Twist, ZEB, and TGF-β) and therapeutic response (chemoresistance and radioresistance). Lastly, we have emphasized the role of exosomal lncRNAs in the regulation of EMT, metastasis, and therapeutic response in the aforementioned cancers. Taken together, this review provides a detailed insight into the understanding of role of lncRNAs/exosomal lncRNAs in EMT, metastasis, and therapeutic response in human cancers.